Carroll Financial Associates’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $4K | Sell |
33
-1
| -3% | -$121 | ﹤0.01% | 1383 |
|
|
2021
Q3 | $4K | Sell |
34
-374
| -92% | -$44K | ﹤0.01% | 1422 |
|
|
2021
Q2 | $72K | Buy |
408
+397
| +3,609% | +$70.1K | ﹤0.01% | 683 |
|
|
2021
Q1 | $1K | Hold |
11
| – | – | ﹤0.01% | 1574 |
|
|
2020
Q4 | $1K | Hold |
11
| – | – | ﹤0.01% | 1466 |
|
|
2020
Q3 | $1K | Hold |
11
| – | – | ﹤0.01% | 1422 |
|
|
2020
Q2 | $1K | Hold |
11
| – | – | ﹤0.01% | 1437 |
|
|
2020
Q1 | $1K | Sell |
11
-75
| -87% | -$6.82K | ﹤0.01% | 1373 |
|
|
2019
Q4 | $12K | Hold |
86
| – | – | ﹤0.01% | 998 |
|
|
2019
Q3 | $11K | Sell |
86
-120
| -58% | -$15.3K | ﹤0.01% | 968 |
|
|
2019
Q2 | $29K | Buy |
206
+6
| +3% | +$845 | ﹤0.01% | 724 |
|
|
2019
Q1 | $28K | Buy |
200
+125
| +167% | +$17.5K | ﹤0.01% | 673 |
|
|
2018
Q4 | $9K | Buy |
+75
| New | +$9K | ﹤0.01% | 888 |
|
|
2018
Q1 | – | Sell |
-11
| Closed | -$1K | – | 1289 |
|
|
2017
Q4 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 1177 |
|
|
2016
Q1 | – | Sell |
-100
| Closed | -$14K | – | 1169 |
|
|
2015
Q4 | $14K | Hold |
100
| – | – | ﹤0.01% | 667 |
|
|
2015
Q3 | $12K | Hold |
100
| – | – | ﹤0.01% | 679 |
|
|
2015
Q2 | $18K | Hold |
100
| – | – | ﹤0.01% | 584 |
|
|
2015
Q1 | $17K | Hold |
100
| – | – | 0.01% | 446 |
|
|
2014
Q4 | $17K | Sell |
100
-60
| -38% | -$10.2K | 0.01% | 411 |
|
|
2014
Q3 | $27K | Hold |
160
| – | – | 0.01% | 406 |
|
|
2014
Q2 | $24K | Hold |
160
| – | – | 0.01% | 442 |
|
|
2014
Q1 | $22K | Hold |
160
| – | – | 0.01% | 408 |
|
|
2013
Q4 | $20K | Hold |
160
| – | – | 0.01% | 414 |
|
|
2013
Q3 | $14K | Hold |
160
| – | – | 0.01% | 476 |
|
|
2013
Q2 | $10K | Buy |
+160
| New | +$10K | ﹤0.01% | 407 |
|